Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SARS Cov2 Vaccination in Adolescents From 12 to 18 With Juvenile Idiopathic Arthritis in Angers, Nantes and Rennes : Acceptance and Safety.

NCT05547451 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT05547451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05547451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SARS Cov2 Vaccination in Adolescents From 12 to 18 With Juvenile Idiopathic Arthritis in Angers, Nantes and Rennes : Acceptance and Safety.
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 9, 2024
Completion date
June 30, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars cov 2 vaccination in adolescents with juvenile idiopathic arthritis